...
首页> 外文期刊>Pediatric blood & cancer >Successful treatment of kaposiform lymphangiomatosis with sirolimus
【24h】

Successful treatment of kaposiform lymphangiomatosis with sirolimus

机译:西罗莫司成功治疗卡波西氏淋巴管瘤病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Generalized lymphatic anomaly (GLA) is a rare and often fatal congenital lymphatic disorder that also commonly affects bone. Kaposiform lymphangiomatosis (KLA) is a novel subtype of GLA with poor prognosis and no proper treatment guidelines. A 9-year-old male with recurrent pleural effusion was clinically diagnosed as KLA. Following sirolimus therapy at a dose of 0.8mg/m(2) twice daily, pleural effusion was significantly decreased and the general status of the patient markedly improved. The clinical course indicates that sirolimus may present an effective therapeutic option in KLA. Moreover, KLA should be considered in differential diagnosis for cases of GLA with coagulopathy. Pediatr Blood Cancer 2015;62:1291-1293. (c) 2015 Wiley Periodicals, Inc.
机译:全身淋巴异常(GLA)是一种罕见的且通常是致命的先天性淋巴疾病,通常也影响骨骼。 Kaposiform淋巴管瘤病(KLA)是一种新型的GLA亚型,预后差,没有适当的治疗指南。一名9岁男性反复胸腔积液被临床诊断为KLA。每天两次以0.8mg / m(2)的剂量进行西罗莫司治疗后,胸腔积液明显减少,患者的总体状况得到明显改善。临床过程表明西罗莫司可能在KLA中提供有效的治疗选择。此外,对于伴有凝血病的GLA病例,在鉴别诊断中应考虑使用KLA。小儿血液癌2015; 62:1291-1293。 (c)2015年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号